Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: Roles of phosphatidylinositol 3-kinase-akt and extracellular signal-regulated kinase

Anesthesiology

Volumn 111, Issue 6, 2009, Pages 1197-1205

  Jiang, Xiaojing ^a   Ai, Chunyu ^a   Shi, Enyi ^a   Nakajima, Yoshiki ^b   Ma, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ENZYME INHIBITOR; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; BALLOON CATHETER; CONDITIONING; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HISTOLOGY; LUMBAR SPINAL CORD; MALE; MOTONEURON; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OBSERVATION; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RENAL ARTERY; REPERFUSION INJURY; SCORING SYSTEM; SHAM PROCEDURE; SPINAL CORD ISCHEMIA; WESTERN BLOTTING; ANIMAL; BLOOD FLOW; CELL COUNT; DRUG ANTAGONISM; ENZYME ACTIVATION; INTRASPINAL DRUG ADMINISTRATION; ISCHEMIC PRECONDITIONING; METABOLISM; MOVEMENT (PHYSIOLOGY); NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION; SPINAL CORD; SPINAL CORD INJURY; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL COUNT; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INJECTIONS, SPINAL; ISCHEMIC PRECONDITIONING; MALE; MOTOR NEURONS; MOVEMENT; NERVOUS SYSTEM DISEASES; ONCOGENE PROTEIN V-AKT; RABBITS; REGIONAL BLOOD FLOW; REPERFUSION; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 73449120402     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bf1d93     Document Type: Article

References (38)

1. Coselli JS, LeMaire SA, Conklin LD, Köksoy C, Schmittling ZC: Morbidity and mortality after extent II thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 2002; 73:1107-1115
2. Safi HJ, Miller CC III, Huynh TT, Estrera AL, Porat EE, Winnerkvist AN, Allen BS, Hassoun HT, Moore FA: Distal aortic perfusion and cerebrospinal fluid drainage for thoracoabdominal and descending thoracic aortic repair: Ten years of organ protection. Ann Surg 2003; 238:372-380
3. Crawford ES, Crawford JL, Safi HJ, Coselli JS, Hess KR, Brooks B, Norton HJ, Glaeser DH: Thoracoabdominal aortic aneurysms: Preoperative and intraopera-tive factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986; 3:389-404
4. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136
5. Zvara DA, Colonna DM, Deal DD, Vernon JC, Gowda M, Lundell JC: Isch-emic preconditioning reduces neurologic injury in a rat model of spinal cord ischemia. Ann Thorac Surg 1999; 68:874-880
6. Toumpoulis IK, Papakostas JC, Matsagas MI, Malamou-Mitsi VD, Pappa LS, Drossos GE, Derose JJ, Anagnostopoulos CE: Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion. J Thorac Cardiovasc Surg 2004; 128:724-730
7. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285:H579-88
8. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J: Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62:74-85
9. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M: Postconditioning inhibits mitochondrial permeability transition. Circulation 2005; 111:194-197 (Pubitemid 40139731)
10. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM: Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phospha-tidylinositol 3-kinase-Akt pathway. Circ Res 2004; 95:230-232
11. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, Zhang S: Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 2008; 39:2362-2369
12. Gao X, Ren C, Zhao H: Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 2008; 86:2505-2511
13. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R, Simon RP: In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: Ischemic postconditioning. J Cereb Blood Flow Metab 2008; 28:232-241
14. Zhao H, Sapolsky RM, Steinberg GK: Interrupting reperfusion as a stroke therapy: Ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006; 26:1114-1121
15. Jiang X, Shi E, Nakajima Y, Sato S: Postconditioning, a series of brief interruptions of early reperfusion, prevents neurologic injury after spinal cord ischemia. Ann Surg 2006; 244:148-153
16. Shi E, Jiang X, Kazui T, Washiyama N, Yamashita K, Terada H, Bashar AH: Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia. J Thorac Cardiovasc Surg 2007; 133:942-948
17. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV: Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44:1103-1110
18. Rehni AK, Singh N: Role of phosphoinositide 3-kinase in ischemic post-conditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep 2007; 59:192-198
19. Choi JS, Kim HY, Cha JH, Lee MY: Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 2006; 409:187-191
20. Zuo Z, Wang Y, Huang Y: Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006; 542:84-91
21. Suzuki K, Kazui T, Terada H, Umemura K, Ikeda Y, Bashar AH, Yamashita K, Washiyama N, Suzuki T, Ohkura K, Yasuike J: Experimental study on the protective effects of edaravone against ischemic spinal cord injury. J Thorac Cardiovasc Surg 2005; 130:1586-1592
22. Shi E, Kazui T, Jiang X, Washiyama N, Yamashita K, Terada H, Bashar AH: Intrathecal injection of bone marrow stromal cells attenuates neurologic injury after spinal cord ischemia. Ann Thorac Surg 2006; 81:2227-2233
23. Tarlov IM: Spinal Cord Compression: Mechanisms of Paralysis and Treatment. Springfield, Illinois, Charles C. Thomas, 1957, p 147
24. Mutch WA, Graham MR, Halliday WC, Thiessen DB, Girling LG: Use of neuroanesthesia adjuncts (hyperventilation and mannitol administration) improves neurological outcome after thoracic aortic cross-clamping in dogs. Stroke 1993; 24:1204-1210
25. Yu F, Narasimhan P, Saito A, Liu J, Chan PH: Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury. J Cereb Blood Flow Metab 2008; 28:44-52
26. Jean WC, Spellman SR, Nussbaum ES, Low WC: Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43:1382-1396
27. Hossmann KA: Reperfusion of the brain after global ischemia: Hemody-namic disturbances. Shock 1997; 8:95-101
28. Zhao H: Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 2009; 29:873-885
29. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J: Reperfusion conditions: Importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986; 92:613-620
30. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M: PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006; 69:178-185
31. Xu X, Chua CC, Gao J, Hamdy RC, Chua BH: Humanin is a novel neuro-protective agent against stroke. Stroke 2006; 37:2613-2619
32. Zhuang S, Schnellmann RG: A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 2006; 319:991-997
33. Niyaz M, Numakawa T, Matsuki Y, Kumamaru E, Adachi N, Kitazawa H, Kunugi H, Kudo M: MCI-186 prevents brain tissue from neuronal damage in cerebral infarction through the activation of intracellular signaling. J Neurosci Res 2007; 85:2933-2942
34. Sun X, Zhou H, Luo X, Li S, Yu D, Hua J, Mu D, Mao M: Neuroprotection of brain-derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol 3-ki-nase. Int J Dev Neurosci 2008; 26:363-370
35. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005; 19:2026-2028
36. Hasegawa Y, Hamada J, Morioka M, Yano S, Kawano T, Kai Y, Fukunaga K, Ushio Y: Neuroprotective effect of postischemic administration of sodium or-thovanadate in rats with transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2003; 23:1040-1051
37. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ: Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113:1535-1549
38. Christophe M, Nicolas S: Mitochondria: A target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Drug Targets 2005; 6:821-833